GL1X · GenesisL1 explorer

MolNFT v1 · #52913 · protein

Human bace-1 in complex with 4-ethyl-N-((1S,2R)-2-hydroxy-1- (phenylmethyl)-3-(((3-(TRIFLUOROMETHYL)PHENYL)METHYL)AMINO)PROPYL)-8- (2-oxo-1-pyrrolidinyl)-6-quinolinecarboxamide

2WF0 · Beta-secretase 1: “Human bace-1 in complex with 4-ethyl-N-((1S,2R)-2-hydroxy-1…”. X-ray diffraction, 1 ligand (ZY0), 2 pockets (best druggability 0.71). MolNFT v1 #52913 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
2WF0
Type
protein
Length
372 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-secretase 1
EC
3.4.23.46
UniProt
P56817
Ligands
ZY0
Pockets
2 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 15% helix, 42% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-secretase 1 (EC 3.4.23.46)protein37215% helix, 42% strandP56817

Ligands and binding sites

  • ZY0 · N-[(1S,2R)-1-benzyl-2-hydroxy-3-{[3-(trifluoromethyl)benzyl]amino}propyl]-4-ethyl-8-(2-oxopyrrolidin-1-yl)quinoline-6-carboxamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14410.710.8167ZY0
2980.450.8022empty

Modifications

Observed in the structure: 3 disulfide (disulfide).

Compared structures

  • 2WF0 · Human BACE-1 in complex with 4-ethyl-N-((1S,2R)-2-hydroxy-1-(phenylmethyl)-3-(((3-(trifluo… · the same entry in another collection · chain A against A, TM-score 1.00
  • P56817 · AlphaFold monomer V2.0 prediction for beta-secretase 1 (P56817) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.